A nurse practitioner who prosecutors said positioned herself as an authority on Medicare compliance while participating in a multimillion-dollar fraud operation has been sentenced to more than seven years in federal prison after being convicted in a scheme involving medically unnecessary cancer genetic testing.
According to the U.S. Department of Justice, Scharmaine Lawson Baker, 59, of Fulshear, Texas, was sentenced to 87 months in prison and three years of supervised release after a federal jury found her guilty on six counts of health care fraud following a July 2025 trial.
Federal prosecutors said the case centered on a telehealth arrangement that generated more than $12 million in false Medicare claims and highlighted growing scrutiny surrounding alleged abuse within remote healthcare systems.
Court documents stated that Baker worked as an independent contractor for a company claiming to provide telehealth services between October 2018 and October 2019. Prosecutors alleged that during that period she signed hundreds of orders for cancer genetic tests that were not medically necessary and did so after brief telephone interactions with patients that often lasted less than 30 seconds.
The government argued that one recorded exchange became particularly significant during trial proceedings.
A phone operator allegedly told Baker she would be “rolling in money” for signing testing orders. Prosecutors said Baker responded: “Honey, I am not complaining.”
Authorities argued the statement illustrated what they characterized as a willingness to prioritize financial incentives over legitimate medical standards.
The Justice Department said evidence presented at trial showed Baker signed orders for ovarian and cervical cancer tests for male patients, which prosecutors cited as proof that she was approving tests without meaningful medical review.
Federal authorities further alleged that Baker did not review test results, including instances in which patients’ screenings identified genetic markers associated with increased cancer risks.
In total, prosecutors said the testing orders generated more than $12.1 million in fraudulent Medicare claims. Laboratories involved in the scheme reportedly received more than $1.5 million in reimbursements from Medicare.
According to the Justice Department, Baker accepted tens of thousands of dollars in kickbacks and bribes connected to the testing orders and later failed to disclose those payments during bankruptcy proceedings.
The investigation was conducted by the Department of Health and Human Services Office of Inspector General and the FBI’s New Orleans Field Office.
The case also arrives as federal authorities continue emphasizing healthcare fraud enforcement as a major priority. The Justice Department said its Health Care Fraud Strike Force Program has charged more than 6,200 defendants since 2007 involving over $45 billion in alleged fraudulent billings.
For legal observers, the case serves as another example of prosecutors using telehealth-related investigations to examine whether rapid expansion of remote healthcare services created opportunities for abuse, particularly where medical necessity standards and compensation structures intersect.
Baker was also ordered to pay $1,508,868.25 in restitution.
Sentencing proceedings are often the final chapter in a criminal case, but healthcare attorneys note that cases involving Medicare billing practices frequently carry broader implications, including provider compliance concerns, licensing consequences, and future scrutiny of telehealth oversight systems.
